Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two pregabalin 150 mg capsule formulations under fasting in healthy Thai subjects
TCTR20230203003Phase 1Completed
- Sponsor
- Changzhou Pharmaceutical Factory
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pregabalin (2 arms), sponsored by Changzhou Pharmaceutical Factory. Started Jul 2023; status: completed.
02
Drugs
pregabalin
Beyond the preview
Go deeper on TCTR20230203003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230203003.